author-photo

Nathalie Kersual

University of Montpellier

3

Papers

50

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.

2014 mAbs
Show All
- Source
- Cite
- Save
Citations (20)
Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.

2013 Nuclear Medicine and Biology
Show All
- Source
- Cite
- Save
Citations (18)
High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging

2013 Journal of Immunological Methods
Show All
- Source
- Cite
- Save
Citations (12)